← Back to Search

Proactive Psychiatry Consultation (PPC) for Major Depressive Disorder

N/A
Waitlist Available
Led By Kelly E Irwin, MD
Research Sponsored by Massachusetts General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months from study enrollment
Awards & highlights

Study Summary

This trial is testing if it's helpful for patients with mental illness to have a psychiatrist and case manager when they're diagnosed with cancer.

Eligible Conditions
  • Major Depressive Disorder
  • Gastrointestinal Cancer
  • Cancer
  • Breast Cancer
  • Bipolar Disorder
  • Schizophrenia
  • Head and Neck Cancers
  • Lung Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months from study enrollment
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months from study enrollment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Disruptions in Cancer Care
Secondary outcome measures
BPRS (24)
PHQ-9

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Proactive Psychiatry Consultation (PPC) - Randomized TrialExperimental Treatment1 Intervention
Proactive Psychiatry Consultation and Case Management is: Patient-centered: Based on the patient's needs, the team aims to build a relationship, increase engagement, and promote continuity. Team-based: A psychiatrist and case manager identify goals for cancer treatment, assess psychiatric history and symptoms with a focus on impact on cancer care, collaborate with community-based clinicians and caregivers, and address barriers to care. Integrated into cancer care delivery: The psychiatry and oncology teams collaborate starting at cancer diagnosis to support patient through cancer treatment. Systematic: The team monitors psychiatric and cancer-related symptoms and cancer care delivery to measure progress toward goals and rapidly adjust treatment as needed.
Group II: Proactive Psychiatry Consultation (PPC) - PILOTExperimental Treatment1 Intervention
Proactive Psychiatry Consultation and Case Management is: Patient-centered: Based on the patient's needs, the team aims to build a relationship, increase engagement, and promote continuity. Team-based: A psychiatrist and case manager identify goals for cancer treatment, assess psychiatric history and symptoms with a focus on impact on cancer care, collaborate with community-based clinicians and caregivers, and address barriers to care. Integrated into cancer care delivery: The psychiatry and oncology teams collaborate starting at cancer diagnosis to support patient through cancer treatment. Systematic: The team monitors psychiatric and cancer-related symptoms and cancer care delivery to measure progress toward goals and rapidly adjust treatment as needed.
Group III: Enhanced Usual Care (EUC) - Randomized TrialActive Control1 Intervention
Study staff will send a templated email to the treating oncologist at enrollment informing the oncologists of the psychiatric diagnosis and available psychosocial services. Study staff will also inform the patient and caregiver of available psychosocial services.

Find a Location

Who is running the clinical trial?

Massachusetts General HospitalLead Sponsor
2,941 Previous Clinical Trials
13,200,483 Total Patients Enrolled
Harvard Risk Management FoundationOTHER
6 Previous Clinical Trials
30,959 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,703 Previous Clinical Trials
40,931,565 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment for this trial open at the moment?

"According to clinicaltrials.gov, the posting for this trial has not been actively seeking participants since January 11th 2022; however, there are 4388 other studies recruiting patients at this time. Originally posted on December 11th 2017, no new applicants are being considered currently."

Answered by AI
~25 spots leftby May 2025